lunes, 30 de mayo de 2016

National Guideline Clearinghouse | Screening for autism spectrum disorder in young children: U.S. Preventive Services Task Force recommendation statement.

U.S. Preventive Services Task Force

Screening for autism spectrum disorder in young children: U.S. Preventive Services Task Force recommendation statement.

Guideline Title

Screening for autism spectrum disorder in young children: U.S. Preventive Services Task Force recommendation statement.

Bibliographic Source(s)

U.S. Preventive Services Task Force. Screening for autism spectrum disorder in young children: U.S. Preventive Services Task Force recommendation statement. JAMA. 2016 Feb 16;315(7):691-6. [22 references] PubMed External Web Site Policy

Guideline Status

This is the current release of the guideline.

This guideline meets NGC's 2013 (revised) inclusion criteria.

------

Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement. - PubMed - NCBI

2016 Feb 16;315(7):691-6. doi: 10.1001/jama.2016.0018.

Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement.

Siu AL1; US Preventive Services Task Force (USPSTF), Bibbins-Domingo K2, Grossman DC3, Baumann LC4, Davidson KW5, Ebell M6, García FA7, Gillman M8, Herzstein J9, Kemper AR10, Krist AH11, Kurth AE12, Owens DK13, Phillips WR14, Phipps MG15, Pignone MP16.

Author information

Abstract

DESCRIPTION:

New US Preventive Services Task Force (USPSTF) recommendation on screening for autism spectrum disorder (ASD) in young children.

METHODS:

The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of brief, formal screening instruments for ASD administered during routine primary care visits and the benefits and potential harms of early behavioral treatment for young children identified with ASD through screening.

POPULATION:

This recommendation applies to children aged 18 to 30 months who have not been diagnosed with ASD or developmental delay and for whom no concerns of ASD have been raised by parents, other caregivers, or health care professionals.

RECOMMENDATION:

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for ASD in young children for whom no concerns of ASD have been raised by their parents or a clinician. (I statement).